MSD Animal Health | Central & Eastern Europe

What MSD Animal Health | Central & Eastern Europe does

MSD Animal Health is the global animal health division of Merck & Co., Inc. (NYSE: MRK), headquartered in Rahway, New Jersey, with regional headquarters for Europe, Africa, and the Middle East (EURAM) located in Brussels, Belgium. The Central & Eastern Europe regional entity operates with 11–50 employees and supports commercial activities across European and Eurasian markets. The division markets a broad portfolio of veterinary pharmaceuticals, vaccines, parasiticides, and connected technology solutions across six business segments: companion animals (dogs, cats), equine, swine, ruminants (cattle), poultry, and aqua (fish/shrimp).

The product portfolio is anchored by several proprietary platforms. BRAVECTO (fluralaner), an isoxazoline-class parasiticide, has distributed more than 350 million doses across 100 countries since 2014 and includes the BRAVECTO QUANTUM 12-month extended-release injectable approved by the FDA in July 2025. NUMELVI (atinvicitinib) is positioned as the first and only second-generation JAK inhibitor approved by the European Commission in July 2025 for canine allergic dermatitis. The HVT vector vaccine platform underpins INNOVAX-ND-IBD-ILT (single-dose poultry vaccine against Newcastle disease, infectious bursal disease, infectious laryngotracheitis, and Marek's disease). Additional product lines include MOMETAMAX SINGLE for canine otitis externa, the NOBIVAC vaccine family (including pending leptospirosis L6/LoVo L6 serovar coverage), NOBILIS MULTRIVA REOm for poultry, BOVILIS NASALGEN-C for bovine coronavirus, and EXZOLT for cattle parasiticides. Connected technology offerings center on Allflex Livestock Intelligence (RFID-based animal identification, monitoring tags, weigh scales, milking automation, and cloud software) plus a Livestock Monitoring subscription program and the LeeO digital swine traceability platform acquired via a 2022 minority investment.

The business model combines one-time product sales of pharmaceuticals and vaccines with recurring subscription revenue from the Livestock Monitoring platform. All pharmaceutical products are dispensed exclusively through licensed veterinarians, ensuring professional channel control and supporting premium pricing on differentiated formulations. Geographic reach spans more than 50 countries with products in approximately 150 markets, and the CEE region represents one of several European commercial clusters under the EURAM umbrella. Distribution agreements include an exclusive global partnership with União Química / Union Agener for LACTOTROPIN recombinant bovine somatotropin. The company invests in veterinary student scholarship programs (notably a 10-year partnership with the Federation of Veterinarians of Europe supporting roughly 400 students) and donates NOBIVAC rabies vaccines through the Afya Program (more than 7 million doses since 1996).

Name

MSD Animal Health | Central & Eastern Europe

Legal name

MSD Animal Health

Website

https://msd-animal-health.com

Company type

Public

Founded year

1891

Operating status

Operating

Headcount range

11–50 employees

Short description

MSD Animal Health is the global animal health division of Merck & Co., Inc., selling veterinary pharmaceuticals, vaccines, parasiticides, and connected livestock technology (Allflex, LeeO) through licensed veterinarians and direct field sales across 50+ countries and six animal segments.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Support Activities for Animal Production (1152)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

akta.pro secondary industries

Veterinary Vaccines (Biologics) (HLAMAEAL), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Companion Animal Vaccines (Dogs & Cats) (HLAMAKAA), Veterinary Vaccines (HLAIAEAH), Veterinary Vaccine & Biologics Distributors (HLAMAIAC)

Keywords

• Veterinary pharmaceuticals
• Animal health vaccines
• Veterinary parasiticides
• Livestock monitoring technology
• Companion animal products

Headquarters

HQ city

Rahway

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Veterinary Pharmaceuticals and Vaccines: Sale of veterinary pharmaceutical products including parasiticides (BRAVECTO), vaccines (NOBIVAC, INNOVAX, BOVILIS), and therapeutic medicines (NUMELVI, MOMETAMAX) to veterinarians, pet owners, farmers, and producers. Revenue is generated through product sales across companion animal and food animal segments.
2. Connected Technology and Monitoring Solutions: Sale and subscription of Allflex Livestock Intelligence products including animal identification tags, monitoring devices, RFID hardware (ear tags, readers, weigh scales), and related software. The company operates a Livestock Monitoring subscription program that provides dairy farmers with real-time data and continuous value.
3. Livestock Monitoring Subscription: Subscription-based model for livestock monitoring technology launched two years ago, now covering multiple dairy monitoring products. Provides farmers with real-time data, up-to-date technology access, and continuous customer support.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

MSD Animal Health develops, manufactures, and sells veterinary pharmaceuticals, vaccines, parasiticides, and connected technology solutions for companion animals (pets, horses) and food-producing animals (swine, ruminants, poultry, aqua). Key brands include BRAVECTO parasiticides, NUMELVI JAK inhibitor, MOMETAMAX otic treatments, NOBIVAC and NOBILIS vaccine families, BOVILIS cattle vaccines, and the Allflex Livestock Intelligence identification and monitoring technology platform. Products are distributed exclusively through licensed veterinarians and direct sales to farmers and producers across more than 50 countries.

Product overview

MSD Animal Health offers a broad portfolio of veterinary pharmaceuticals, vaccines, parasiticides, and technology solutions organized across six animal health segments: Companion Animal (pets), Equine (horses), Swine, Ruminants (cattle), Poultry, and Aqua (aquatic species). The product portfolio centers on key brands including BRAVECTO (fluralaner-based parasiticides in multiple formulations including QUANTUM injectable and chews), NUMELVI (second-generation JAK inhibitor for allergic dermatitis in dogs), MOMETAMAX otic treatments, NOBIVAC and NOBILIS vaccine families (including L6 leptospirosis vaccines, NXT HCPChFeLV for cats, MULTRIVA REOm for poultry, INNOVAX-ND-IBD-ILT multivalent poultry vaccine), and BOVILIS NASALGEN-C for bovine coronavirus. Technology offerings include Allflex Livestock Intelligence (animal identification and monitoring with RFID-based ear tags, readers, and weigh scales), LeeO Precision Farming (cloud-based swine traceability), and a Livestock Monitoring subscription platform. The company also distributes LACTOTROPIN (recombinant bovine somatotropin) through a partnership with Union Agener Animal Health. Through the Afya Program, MSD Animal Health donates NOBIVAC rabies vaccines to combat rabies in underserved communities.

Differentiator

Problem solved

Functional benefit

Brands

• Allflex Livestock Intelligence: Global leader in animal identification and monitoring devices for livestock management
• BRAVECTO
• NUMELVI
• BOVILIS
• NOBILIS
• NOBILIS MULTRIVA
• MOMETAMAX
• LACTOTROPIN
• INNOVAX
• NOBIVAC
• LeeO
• EXZOLT

Quantifiable outcome

• BRAVECTO injectable: 100% reduction in live fleas from Day 10 and 99.8%+ efficacy maintained for 365 days
• +7 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered core.

• Federation of Veterinarians of Europe (FVE)coreStrategic or Co-development Partner · 9 February 202610-year partnership providing veterinary student scholarships across Europe. Over 10 years, nearly 400 veterinary students and young professionals have been awarded scholarships through the MSD Animal Health–FVE Scholarship Program. For 2025, 34 students from 25 veterinary faculties in 17 countries were selected from 132 applications. Supported by EAEVE and IVSA.
• Rabies Free Africa and Mission RabiescoreStrategic or Co-development Partner · 25 September 2025Through the Afya Program (founded 1996), MSD Animal Health partners with Rabies Free Africa, Mission Rabies, governments, and local communities to eliminate rabies through canine vaccination campaigns and community education. More than 7 million NOBIVAC rabies vaccines donated; more than 12 million people educated about rabies.
• União Química / Union Agener Animal HealthcoreChannel Partner/ Reseller/ Distributor · 24 February 2025Exclusive global distribution agreement for LACTOTROPIN recombinant bovine somatotropin, which increases milk production in lactating dairy cows starting 60 days postpartum. MSD Animal Health is exclusive distributor globally except Mexico, South Africa, and the United States. In Brazil, co-distribution with Union Agener. LACTOTROPIN is produced at Union Agener's facility in Augusta, Georgia, USA.
• LeeO Precision Farming B.V.coreStrategic or Co-development Partner · 27 September 2022MSD Animal Health completed a minority investment in LeeO Precision Farming B.V., a Dutch company providing cloud-based real-time digital swine traceability solutions. MSD Animal Health also assumed distribution of LeeO's digital swine traceability solution in selected markets. LeeO provides RFID-based hardware (ear tags, readers, weigh scales) integrated with cloud software for tracking swine from birth throughout their lifecycle.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Hester Biosciences: India-based animal health vaccine manufacturer with growing poultry and livestock vaccine portfolio across South Asia and emerging markets. Emerging peer in poultry vaccines competing against NOBILIS and INNOVAX franchises.
• Indian Immunologicals: Indian animal and human biologicals manufacturer producing veterinary vaccines and diagnostics with expanding emerging-market presence. Emerging peer in livestock vaccines, particularly in South Asia where MSD Animal Health also operates.

Direct peers

• Ceva Santé Animale: French-headquartered global animal health company with strong positions in poultry vaccines, ruminant reproduction and companion animal pharmaceuticals. Direct competitor in poultry (NOBILIS) and swine segments.
• Vetoquinol: French-headquartered animal health pharmaceutical company with companion animal and livestock products across Europe and North America. Direct peer in vet-pharma, particularly in dermatology and ruminant therapeutics.
• Elanco Animal Health: Global animal health company formed via the Bayer Animal Health acquisition, with competing parasiticides (Credelio), vaccines and companion-animal dermatology products. Direct competitor in the isoxazoline class and across companion animal therapeutics.
• Zoetis: Largest pure-play global animal health company, offering vaccines, parasiticides, diagnostics and technology across companion and livestock species. Directly competes with MSD Animal Health in parasiticide, vaccine and dermatology franchises, including the Simparica/Simparica Trio isoxazoline line.
• Virbac: French global animal health company focused on companion animal parasiticides, dermatology, and food animal products. Direct competitor in dermatology (competing with MOMETAMAX and NUMELVI) and livestock therapeutics.
• Boehringer Ingelheim Animal Health: Second-largest global animal health business with a broad portfolio of vaccines, parasiticides (NexGard/NexGard Spectra) and therapeutics across companion and production animals. Direct competitor to BRAVECTO, NOBIVAC and INNOVAX franchises.

Broad incumbents

• Phibro Animal Health: Animal health and nutrition company with vaccines, parasiticides and nutritional specialty products focused on production animals. Overlapping competitor in livestock vaccines and nutritional pharmaceuticals.
• IDEXX Laboratories: Global leader in veterinary diagnostics with companion animal practice software and reference lab services. Adjacent rather than directly competitive, but a strategic incumbent in the vet channel where MSD Animal Health distributes its pharmaceuticals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/MSDAnimalHealth
• YouTubeyoutube.com/channel/UCZCh6j3EqRpbXtg9gslfd8Q
• LinkedInlinkedin.com/company/msdanimalhealthcee

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MSD Animal Health | Central & Eastern Europe